000 01221 a2200385 4500
005 20250510212247.0
264 0 _c19800226
008 198002s 0 0 eng d
022 _a0171-967X
024 7 _a10.1007/BF02441226
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLidgren, L
245 0 0 _aBone mineral content in epileptics.
_h[electronic resource]
260 _bCalcified tissue international
_cOct 1979
300 _a99-102 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAged
650 0 4 _aBone and Bones
_xanalysis
650 0 4 _aCarbamazepine
_xtherapeutic use
650 0 4 _aEpilepsy
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMinerals
_xanalysis
650 0 4 _aMuscle Contraction
650 0 4 _aMuscle Tonus
650 0 4 _aOsteomalacia
_xchemically induced
650 0 4 _aPhenobarbital
_xtherapeutic use
650 0 4 _aPhenytoin
_xtherapeutic use
700 1 _aNilsson, B E
700 1 _aWallöe, A
773 0 _tCalcified tissue international
_gvol. 28
_gno. 2
_gp. 99-102
856 4 0 _uhttps://doi.org/10.1007/BF02441226
_zAvailable from publisher's website
999 _c114533
_d114533